Trial intelligence / Profile preview

Omega-3 in prevention of renal scars in pyelonephritis

IRCT2015062922965N1Phase 3Completed

Sponsor
Vice Chancellor for research of Hamadan University of Medical Sciences
Start
Jan 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of omega-3 fatty acid in pyelonephritis and kidney fibrosis, sponsored by Vice Chancellor for research of Hamadan University of Medical Sciences. Started Jan 2014; status: completed.

02

Drugs

omega-3 fatty acid
03

Conditions

pyelonephritiskidney fibrosis

Beyond the preview

Go deeper on IRCT2015062922965N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2015062922965N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call